127 related articles for article (PubMed ID: 11136385)
21. Prospective surveillance study of haemophilia A patients switching from moroctocog alfa or other factor VIII products to moroctocog alfa albumin-free cell culture (AF-CC) in usual care settings.
Parra Lopez R; Nemes L; Jimenez-Yuste V; Rusen L; Cid AR; Charnigo RJ; Baumann JA; Smith L; Korth-Bradley JM; Rendo P
Thromb Haemost; 2015 Oct; 114(4):676-84. PubMed ID: 26293201
[TBL] [Abstract][Full Text] [Related]
22. A postmarketing surveillance study of the safety and efficacy of ReFacto (St Louis-derived active substance) in patients with haemophilia A.
Smith MP; Giangrande P; Pollman H; Littlewood R; Kollmer C; Feingold J;
Haemophilia; 2005 Sep; 11(5):444-51. PubMed ID: 16128886
[TBL] [Abstract][Full Text] [Related]
23. [French guidelines. Long-term prophylaxis for severe haemophilia A and B children to prevent haemophiliac arthropathy].
Meunier S; Trossaërt M; Berger C; Borel-Derlon A; Dirat G; Donadel-Claeyssens S; Assolant AD; Guérois C; Lutz P; Rafowicz A; Rothschild C; Chambost H;
Arch Pediatr; 2009 Dec; 16(12):1571-8. PubMed ID: 19960603
[TBL] [Abstract][Full Text] [Related]
24. Treatment decisions and usage of clotting factor concentrate by a cohort of Indian haemophilia patients.
Dharmarajan S; Gund P; Phadnis S; Lohade S; Lalwani A; Kar A
Haemophilia; 2012 Jan; 18(1):e27-9. PubMed ID: 21981421
[No Abstract] [Full Text] [Related]
25. The future of plasma-derived clotting factor concentrates.
Hoots WK
Haemophilia; 2001 Jan; 7 Suppl 1():4-9. PubMed ID: 11240612
[TBL] [Abstract][Full Text] [Related]
26. Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey.
Zappa S; McDaniel M; Marandola J; Allen G
Haemophilia; 2012 May; 18(3):e140-53. PubMed ID: 22533455
[TBL] [Abstract][Full Text] [Related]
27. Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors.
Iorio A; Matino D; D'Amico R; Makris M
Cochrane Database Syst Rev; 2010 Aug; (8):CD004449. PubMed ID: 20687076
[TBL] [Abstract][Full Text] [Related]
28. FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations.
Perry D; Berntorp E; Tait C; Dolan G; Holme PA; Laffan M; Lassila R; Mumford A; Pasi J; Wilde J; Will A; Yee TT
Haemophilia; 2010 Jan; 16(1):80-9. PubMed ID: 19780845
[TBL] [Abstract][Full Text] [Related]
29. A retrospective study of Octaplex in the treatment of bleeding in patients with haemophilia A complicated by inhibitors.
Berntorp E; Figueiredo S; Futema L; Pock K; Knaub S; Walter O; Trawnicek L; Römisch J
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):577-83. PubMed ID: 20644466
[TBL] [Abstract][Full Text] [Related]
30. Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies.
Carcao M; Chambost H; Ljung R
Haemophilia; 2010 Mar; 16 Suppl 2():4-9. PubMed ID: 20132332
[TBL] [Abstract][Full Text] [Related]
31. [Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients].
Briët E; Mauser-Bunschoten EP
Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2566-71. PubMed ID: 9555158
[TBL] [Abstract][Full Text] [Related]
32. Dose and outcome of care in haemophilia--how do we define cost-effectiveness?
Fischer K; Van den Berg HM; Thomas R; Kumar S; Poonnoose P; Viswabandya A; Mathews V; Kavitha ML; Bhattacharji S; Srivastava A
Haemophilia; 2004 Oct; 10 Suppl 4():216-20. PubMed ID: 15479401
[TBL] [Abstract][Full Text] [Related]
33. Prophylaxis in haemophilia with inhibitors: update from international experience.
Carcao M; Lambert T
Haemophilia; 2010 Mar; 16 Suppl 2():16-23. PubMed ID: 20132334
[TBL] [Abstract][Full Text] [Related]
34. Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment.
Den Uijl I; Mauser-Bunschoten EP; Roosendaal G; Schutgens R; Fischer K
Haemophilia; 2009 Nov; 15(6):1215-8. PubMed ID: 19686467
[TBL] [Abstract][Full Text] [Related]
35. Endogenous clotting factor activity and long-term outcome in patients with moderate haemophilia.
Fischer K; van der Bom JG; Mauser-Bunschoten EP; Roosendaal G; Beek FJ; de Kleijn P; Grobbee DE; van den Berg HM
Thromb Haemost; 2000 Dec; 84(6):977-80. PubMed ID: 11154144
[TBL] [Abstract][Full Text] [Related]
36. Kreuth III: European consensus proposals for treatment of haemophilia with coagulation factor concentrates.
Giangrande P; Seitz R; Behr-Gross ME; Berger K; Hilger A; Klein H; Schramm W; Mannucci PM
Haemophilia; 2014 May; 20(3):322-5. PubMed ID: 24731129
[TBL] [Abstract][Full Text] [Related]
37. Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey.
Franchini M; Coppola A; Rocino A; Zanon E; Morfini M; ; Accorsi A; Aru AB; Biasoli C; Cantori I; Castaman G; Cesaro S; Ciabatta C; De Cristofaro R; Delios G; Di Minno G; D'Incà M; Dragani A; Ettorre CP; Gagliano F; Gamba G; Gandini G; Giordano P; Giuffrida G; Gresele P; Latella C; Luciani M; Margaglione M; Marietta M; Mazzucconi MG; Messina M; Molinari AC; Notarangelo LD; Oliovecchio E; Peyvandi F; Piseddu G; Rossetti G; Rossi V; Santagostino E; Schiavoni M; Schinco P; Serino ML; Tagliaferri A; Testa S
Haemophilia; 2014 Mar; 20(2):e128-35. PubMed ID: 24533954
[TBL] [Abstract][Full Text] [Related]
38. Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B.
Wang C; Young G
Haemophilia; 2018 May; 24(3):414-419. PubMed ID: 29405496
[TBL] [Abstract][Full Text] [Related]
39. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
Ahnström J; Berntorp E; Lindvall K; Björkman S
Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
[TBL] [Abstract][Full Text] [Related]
40. Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death.
Stieltjes N; Calvez T; Demiguel V; Torchet MF; Briquel ME; Fressinaud E; Claeyssens S; Coatmelec B; Chambost H;
Haemophilia; 2005 Sep; 11(5):452-8. PubMed ID: 16128887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
